about
Amplification of autoimmune disease by infectionImmunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus modelHost defense against viral infection involves interferon mediated down-regulation of sterol biosynthesisAntiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.Manipulation of Viral MicroRNAs as a Potential Antiviral Strategy for the Treatment of Cytomegalovirus Infection.Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection.Polycomb repressive complex 2 targets murine cytomegalovirus chromatin for modification and associates with viral replication centers.Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replicationInflation and long-term maintenance of CD8 T cells responding to a latent herpesvirus depend upon establishment of latency and presence of viral antigens.Macrophage activation associated with chronic murine cytomegalovirus infection results in more severe experimental choroidal neovascularization.Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.Lack of XBP-1 impedes murine cytomegalovirus gene expression.Mouse cytomegalovirus crosses the species barrier with help from a few human cytomegalovirus proteinsCytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivationVirus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2Increasing inflationary T-cell responses following transient depletion of MCMV-specific memory T cells.Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.Human cytomegalovirus persistence.Immediate-Early (IE) gene regulation of cytomegalovirus: IE1- and pp71-mediated viral strategies against cellular defensesLymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus.Glial cell activation, recruitment, and survival of B-lineage cells following MCMV brain infectionNeonatal neural progenitor cells and their neuronal and glial cell derivatives are fully permissive for human cytomegalovirus infectionCell cycle-independent expression of immediate-early gene 3 results in G1 and G2 arrest in murine cytomegalovirus-infected cells.In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation.Establishment of murine cytomegalovirus latency in vivo is associated with changes in histone modifications and recruitment of transcriptional repressors to the major immediate-early promoter.Rhesus CMV: an emerging animal model for human CMV.The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs.Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity.Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivationDevelopment of a vivo rabbit ligated intestinal Loop Model for HCMV infectionDeveloping a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?γδ T Cell-Mediated Immunity to Cytomegalovirus Infection.Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs.Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection.Tissue-specific control of latent CMV reactivation by regulatory T cells.Deletion of the rat cytomegalovirus immediate-early 1 gene results in a virus capable of establishing latency, but with lower levels of acute virus replication and latency that compromise reactivation efficiency.UL36 Rescues Apoptosis Inhibition and In vivo Replication of a Chimeric MCMV Lacking the M36 Gene.Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells.
P2860
Q24804390-645C7997-D59F-4141-9EBA-CE18651339F0Q27026924-5A4BD4D5-987D-4AA7-9AF8-E7AF55733AEDQ28477369-A1E9E62B-9C74-41CD-BC3B-53C83B915691Q33695591-16F3C0E0-00D0-4450-93F7-248A7D48BA92Q33753996-CE291B16-9937-4CE5-9958-ECBDE2AF9432Q34064200-3110E982-048D-49F1-AA5D-6441C0663F7BQ34141621-4A785859-DA9F-4D5D-AF0D-E2C0CA88B3A6Q34165203-2DBFC423-0445-4992-AF8F-EFBF9A910711Q34165261-9417275D-4E1C-48FB-821E-70549C77A9EDQ34263026-D32E3C8E-8436-4C8D-A29C-E3A177447868Q34360228-8E2F3AF9-C4B4-463D-9A57-B807878D082AQ34380313-8CA43BA4-25C3-43B2-9836-C339FB8857D2Q35023724-E88E4FD9-E175-4902-8FC5-17E261DF79C4Q35086196-E74DB70D-6A0A-4B3F-AA5D-EB2E9C612D15Q35139332-7720DC02-9E43-4489-BA6F-49EBF95AE3A4Q35382985-86C4FC66-ECD2-46B7-843D-2D36EFEBFAD3Q35771566-C02CA6BB-98F2-471E-A9DA-0B3679D5A99BQ35846755-6308F90E-333E-42AE-8B84-9B5ACE2A8866Q35899274-F75E270D-353B-4620-B200-DC088BB19A92Q36304265-5BF89EC6-0170-4803-A687-E9FB79CFF580Q36827145-90C6E701-6EFF-4A6F-818F-8BFB4059AEADQ36919822-C427EADC-FBB6-47AA-9255-D0ACDAFF6BEFQ36933966-56A83A9D-5A87-46E0-960D-D3F7470A44A9Q36933982-C64E321D-03DF-4E2C-A478-9A0E4596CCD8Q36934017-5DED7B65-D548-41B1-8C0C-F75760C9BDFBQ36949670-F1AABE41-F1DD-4B33-A694-FD20152C88D9Q37056384-888959A6-BF31-4E07-8C16-1BAD8A9C6CBFQ37157169-7A5166A8-D785-4970-B86A-07699BC71400Q37243886-FBD69B36-146E-4B57-896D-A5FF411D7F1CQ37275028-C459DCDC-F46C-40F8-AEEF-4C3603EA71D5Q37333761-C80387D7-9218-471B-B7EA-2D3E368D31EEQ37498722-A91B4AFF-3D2D-42A0-942A-EE84AC719DCBQ37574334-30EE844D-4C44-427C-A560-C833E410A2F0Q37632938-5C9A715A-E458-45B0-B0B3-F252D8772D39Q37747368-31CF806A-0959-456F-9230-DE4FB1A23F99Q38044678-F6F8285F-8B3C-48EE-A4A0-CAD5330E7005Q38630384-424D1DCD-5499-4ADF-89DB-3D0EA2682BF6Q38692901-1934A969-787C-477F-8626-F42570B0490CQ40097178-F3B84B2C-B656-42F0-8B7C-B055AB761172Q40102782-2D2ECFB9-95E5-4543-890C-727E60EBD9C1
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mouse models of cytomegalovirus latency: overview.
@ast
Mouse models of cytomegalovirus latency: overview.
@en
Mouse models of cytomegalovirus latency: overview.
@nl
type
label
Mouse models of cytomegalovirus latency: overview.
@ast
Mouse models of cytomegalovirus latency: overview.
@en
Mouse models of cytomegalovirus latency: overview.
@nl
prefLabel
Mouse models of cytomegalovirus latency: overview.
@ast
Mouse models of cytomegalovirus latency: overview.
@en
Mouse models of cytomegalovirus latency: overview.
@nl
P2093
P1476
Mouse models of cytomegalovirus latency: overview.
@en
P2093
Jürgen Podlech
Matthias J Reddehase
Natascha K A Grzimek
P304
P356
10.1016/S1386-6532(02)00087-2
P478
25 Suppl 2
P577
2002-08-01T00:00:00Z